Purpose: Prostate cancer ranks as one of the most common malignancies and currently represents the second leading cancer-specific cause of death in men. The current use of single 10 modality transrectal ultrasound (TRUS) for biopsy guidance is limited in its ability to accurately identify cancerous lesions within the prostate. This study introduces a novel prostate cancer imaging method that combines TRUS with electrical impedance tomography (EIT) and reports on initial clinical findings based on in vivo measurements.
Introduction
Prostate cancer ranks as one of the most common malignancies and in 2010 represented the second leading cancer-specific cause of death in men [1] . Excessive levels of serum prostate specific antigen (PSA) and abnormal digital rectal examination (DRE) represent the current clinical screening methods for prostate cancer. Positive findings reported from either of these 35 procedures are typically followed by transrectal ultrasound (TRUS) guided biopsy, which is the standard protocol for establishing diagnosis and staging disease. Because both PSA and DREbased diagnoses have low sensitivity (<30%) [2] [3] , diagnostic confirmation of prostate cancer relies solely on these TRUS-guided biopsy findings with histology-based measurements including Gleason grade [4] and tumor involvement largely influencing therapeutic staging.
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Unfortunately, numerous studies suggest that due to spatial sampling shortcomings, there are differences in Gleason grades between biopsy and prostatectomy specimens, suggesting that biopsy-based diagnosis does not provide a fail-safe way to determine the stage of the cancer [5] .
Further, TRUS imaging has limited sensitivity and specificity (a miss rate of approximately 40% reported in one study [6] ) for identifying the pathology of focal lesions during these biopsy 45 procedures [7] .
Multiple ex vivo studies report that significant electrical property differences exist between cancerous and benign tissues in the prostate [8] [9]. Specifically, cancerous tissue has a significantly lower conductivity (σ) than benign tissue (p < 0.05) at frequencies ranging from 0.1 kHz to 100 kHz, and a significantly larger permittivity (ε) at 100 kHz (p < 0.0001) in ex vivo 50 studies [10] . Significant contrasts in electrical properties have also been reported between different grade prostate cancers [11] . These electrical property differences result from morphological variations present between cancer and benign tissues. Cancerous tissues consist of a large number of small, deformed, epithelial cell-lined lumens with decreased levels of extracellular fluids as compared to benign tissue, where fewer cells, more uniform luminal 55 structures, and higher levels of extracellular fluids are found. Conductivity is typically associated with ionic charge transfer through biological fluids, while permittivity is associated with charge storage at cellular membranes. The low levels of extracellular fluid and high density of cells in cancerous prostate are hypothesized to lead to the lower conductivity and higher permittivity observed, respectively, under ex vivo conditions. These significant contrasts suggest that methods 60 capable of measuring these properties in vivo may prove useful for cancer detection.
Electrical impedance tomography (EIT) is an imaging modality capable of estimating the internal spatial distribution of conductivity and permittivity based on measured physical quantities (currents and voltages) recorded from electrodes positioned on an object's surface. In medical EIT applications, a number of electrodes are attached to a patient's surface. Low 65 amplitude alternating currents (AC) are injected into the patient and voltages are measured on some or all of the electrodes simultaneously. The boundary currents and voltages, along with the geometry of the object, are used to mathematically estimate the internal conductivity and permittivity by solving a severely ill-posed, non-linear "Calderón's Inverse Problem" [12] using a finite element method (FEM) approach [13] [14] .
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An ultrasound coupled transrectal electrical impedance tomography (TREIT) system [15] with a dedicated reconstruction algorithm [16] has been developed for prostate imaging. The imaging system consists of an EIT data acquisition module, a transrectal ultrasound (TRUS) imaging module, a system control computer, a visual display monitor and a medical-grade isolated power supply [17] . Ultrasound provides a priori anatomical information to guide EIT 75 image reconstruction. Thirty gold-plated electrodes are printed on a 1 mil thick flexible Kapton circuit board and configured along the periphery of a rectangular opening (20 mm× 60 mm). This flexible circuit is wrapped around the shaft of the TRUS probe such that the opening is aligned with the probe's acoustic window and held in place by a pressure sensitive adhesive layer. The window size exceeds that of the TRUS probe's field-of-view (FOV) and enables TREIT imaging 80 of any sized prostate that fits within the TRUS FOV. The addition of this thin flexible circuit does not appreciably increase the diameter of the TRUS probe so no additional patient discomfort is experienced. A circular external ventral electrode is placed on the patient's lower abdomen to provide a return path for currents directed away from the prostate (Fig.1) . Previous imaging studies have demonstrated that this TREIT system is able to detect high contrast inclusions of 1.0 cm in diameter, positioned 2.3 cm away from the probe surface. The system is also capable of differentiating inclusions with 20% contrast to the background [15] , 90 which is less than the reported electrical impedance contrast observed between cancer and benign prostate [10] . This report presents a method to evaluate the TREIT system's ability to detect cancer in the prostate based on correlating electrical properties found in EIT reconstruction with the pathological findings.
Methods
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A. In vivo Patient Imaging Protocol
In vivo ultrasound and TREIT data has been acquired from a total of 57 men diagnosed with prostate cancer prior to their undergoing radical prostatectomy. Ultrasound gel and an electrically translucent natural membrane sheath [18] were applied to interface the TREIT probe to the patient's rectum. The shape and size of the prostate was captured by 3D TRUS, which 
B. EIT Reconstruction with a priori information
Ultrasound image stacks consist of 13 or 61 frames of 2D cross-sectional transverse images 110 (depending on a specified step-size of 5 mm or 1 mm) recorded from each patient. The image stack is ported to a commercial medical image processing software Mimics 13.1 (Materialise Group, Leuven, Belgium) and each 2D transverse frame is manually segmented. After all frames are segmented, a surface mesh with configurable density and smoothness is generated to accurately match the US-based anatomic geometry of the prostate (Fig. 2) . The US derived prostate surface is embedded into a 3D cylindrical mesh containing the probe and electrode geometry (Fig. 3) . A priori anatomic information provided by the embedded prostate is used to guide EIT image reconstruction [19] . The ultrasound image stack is co-125 registered with the cylindrical mesh for reconstruction using a rigid transformation to maintain its correct position in relation to the TRUS probe [20] . After the prostate surface mesh is properly oriented and positioned relative to the probe, the coupled geometric surfaces are processed to generate a volumetric FEM mesh containing the TRUS probe, electrodes, and correctly positioned prostate.
130
For sufficiently low frequencies of injected currents (<1 MHz) a quasistatic approximation is typically used to model the EIT problem. In this case, the fundamental equation in EIT becomes:
where √ 1, is the frequency of the injected current, and is the scalar potential field in 135 an enclosed body Ω . For simplicity, the complex admittivity can be used to represent the conductivity and permittivity. Assuming that a voltage is applied on electrode ( 1,2,3, … , ) located on the domain's surface, Ω, this leads to the following boundary conditions:
where is the contact impedance between the electrode and the body surface, is the outward normal vector extending from the surface, is the surface area of electrode , and is the current measured at electrode [12] [21] . Estimating internal conductivity and permittivity 145 from finite observed measurements on the surface represents an ill-conditioned inverse problem that often leads to unstable solutions due to amplification of errors from both measurements and numerical rounding. In practice, Tikhonov regularization is used to penalize the oscillatory conductivities in solving the inverse problem [22] .
In this application, difference imaging is employed for EIT reconstruction in order to 150 minimize systematic errors from the imaging system. A reference data set is recorded by imaging a saline bath with a conductivity of 0.1 S/m immediately following clinical data acquisition. 3D
reconstructions are computed based on the impedance differences measured between the reference data set and patient data set using the algorithms presented by Borsic et al [16] . Each tetrahedron in the mesh is assigned a value to reflect the complex conductivity (relative to the 0.1
155
S/m reference saline tank) and the vertices of each tetrahedron represent a voltage potential.
The conductivity distribution is generally reconstructed by fitting the calculated measurements to the real measurements and minimizing the error in norm:
The penalty term is added to regularize the ill-posed EIT inverse problem by 160 assuming that the conductivity changes gradually inside the imaging volume. is a matrix of partial differential operators (typically a Laplacian is used) and is a reference admittivity (known from estimation or anatomic structure). Equation (5) is commonly termed Tikhonov regularization and is a scalar or complex regularization factor. In this study, 200 was empirically chosen for patient EIT reconstruction. Note that this method of regularization 165 imposes a degree of spatial averaging due to the nodal-weighting provided through the Laplacian matrix, but is necessary for solving the ill-posed inverse problem.
A coarse FEM mesh (with fewer elements) is typically used in EIT to reduce the illconditioning of the inverse problem (due to the small number of measurements) and the computational complex parameter estimation [16] . In this TREIT application, the high-density 170 patient specific prostate volume mesh (which contains tens of thousands of tetrahedra) is discretized into an 8 8 8 pixelated coarse mesh for parameter estimation as a compromise between sensitivity (influencing image resolution) and noise (larger negative impact with denser meshes) [19] .
This choice is driven by both the computational considerations and the available contrast impedance measurements to contain cancer with a high level of sensitivity and specificity (~70%) [10] . The 8 8 8 coarse mesh elements represent similar volumes to these previous findings and were chosen to potentially enable pixel-based cancer identification of cancer in a computationally efficient way.
The cuboidal coarse mesh circumscribes the prostate region and is uniformly discretized 185 to 8 pixels in each of the x, y and z directions to provide a uniform resolution in all directions.
The reconstruction algorithm constrains the complex conductivity to a single value within each of the coarse pixels. In addition, the complex conductivity outside the prostate region is constrained to converge to a single value during reconstruction. The complex conductivity distribution is linearly solved by:
where is the Jacobian of evaluated at and .
C. Correlating Pathological Findings and EIT Images
Resected prostates were examined by a pathologist to document cancer distribution within the gland. The prostate specimen is sectioned along its axis into 7 to 15 slices depending on the the prostate is assumed to be uniformly sliced for this analysis. In order to correlate estimated conductivity and permittivity profiles of the prostate to the actual histological findings, the TREIT-based reconstructed prostate volume is sectioned along the axis at equal intervals to generate a number of 2D cross-sectional transverse plane views of the electrical properties. The number of the planes is selected to be the same as the number of 210 slices sectioned clinically so that each electrical property image corresponds to a single pathology map.
Before corresponding images can be compared, the elliptical slices in the pathological maps are spatially transformed to match the actual shape of the prostate as defined by ultrasound; this shape is reflected in the stack of sampled 2D EIT reconstruction planes. A thin plate spline 215 transformation technique is used to morphologically transform the pathological maps [23] .
Multiple landmark points are selected on the prostate boundary from each slice of both the EIT images and pathological maps. These points are equally spaced around the periphery of the prostate in both images. Based on the multiple pairs of landmark points, each point in the pathology map is transformed to a correspondingly new position. Finally, the morphed 220 pathological maps are resized to match the corresponding EIT 2D plane so that the prostate in both images is equivalently scaled, which is essential for a pixel based data analysis (Fig. 5) . 
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D. Data analysis
For data analysis purposes, the pathological map can be overlaid onto the EIT 2D plane image to specify cancerous and benign regions within the EIT image. For each individual patient and frequency, all pixels within the EIT slices identified as cancer are averaged to produce a single 
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In addition, mean conductivity, , and permittivity, , for all patients are computed from averaging the individual conductivity and permittivity means (i.e. ∑ _ ), where N is the total number of cases. Standard deviations are also calculated from the individual means to evaluate cross-patient variability.
Results
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A. Image Transformation
The number of landmark points sufficient for accurately performing the pathological map transformation was determined by morphing one map to match its corresponding EIT slice using 4, 8, 20 and 50 landmark points (Fig. 6 ). Each row of performance can be visually assessed by examining the overlap (yellow) of the transformed boundary and the target boundary. As indicated in the comparison images, the transformation accuracy improves with increased landmark points. In the transformation using only 4 landmark points, there is shape mismatch (lower right) due to insufficient sampling along the prostate boundary (Fig. 6) . The effect that the number of landmark points has on the transformation is quantified by calculating the percentage of pixels falling outside the target boundary (i.e. transformation error).
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Specifically, binary images ( and ) are defined for both the target and transformed image such that the pixels within the prostate boundary are assigned "1" while the pixels outside the prostate boundary are assigned "0". The mismatch image is defined as , where designates pixel-based XOR operation. The transformation error is calculated as the ratio of the number of "1"s in the mismatch image to the number of "1"s in the target image. In 275 addition, computation time to calculate the transformation is recorded. As expected, the transformation error decreases and computation time increases with the growing number of landmark points (Table 1) .
A total of 381 pathological map transformations were performed for clinical data analysis using 20 landmark points; the average transformation error for warping this cohort of images is 280 1.67%. In 13 cases, the TRUS probe was positioned sub-optimally within the rectum such that only part of the prostate was within the imaging field of view (i.e. only the apical half of the 300 prostate was imaged). For these cases, only the pathological slices actually imaged by TREIT are included for analysis. Example EIT reconstructions are shown in Fig. 7 and Fig. 8 . The 3D reconstruction ( When the sample of differences ( _ ), are compare across patients, paired one-sample Student's t-tests revealed several significant differences when the valid data from all patients was analyzed 330 (Table 2 ). At lower frequencies of 0.4 kHz, 3.2 kHz and 25.6 kHz, the t-test suggests that the conductivity of cancerous regions is significantly greater than that of benign tissue on a per patient basis, while at 102.4 kHz the conductivity of tumor is significantly less (p = 0.0315, Table 2 ) than that of benign tissues. No significant permittivity differences were observed between the two tissue types at any of the four frequencies.
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The mean (and standard deviation) of conductivity and permittivity for both tissue types across patients ( , , , and ) are tabulated in Table 3 and graphed in Fig. 9 and Fig. 10 .
While not significantly different, mean tumor conductivity is greater than that of benign tissues at frequencies lower than 25.6 kHz (33.5 mS/m vs. between tumor and benign prostatic tissue are not observed to be significant in this cohort. This lack of significance in and when all patients are grouped arises from the considerable standard deviations as compared to the averaged means for both tissue types; this suggests that there is a moderately large patient-to-patient variability. 
Discussion
Pathological maps based on the tissue's morphological appearance are considered the reference 360 for defining cancer distribution in this study. Although small errors may exist in drawing the cancerous regions by hand, the pathological maps still depict the cancer location in the prostate slice with a sufficiently high degree of precision. By providing a histology-based reference, the correlation algorithm presented here is robust in the sense that it can also be applied to verify and evaluate other medical imaging methods.
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Twenty landmark points were used in transforming the pathological map for clinical data analysis. This choice represented a compromise between accuracy and speed; the prostate shape was largely maintained (transformation error =1.67%) while computational effort was ~25% more efficient than using 50 landmark points.
The significant in vivo electrical property differences observed between malignant and 370 benign tissues detected by the TREIT imaging system suggest potential clinical value in identifying cancerous regions. Paired-testing revealed that at frequencies ranging from 0.4 kHz to 25.6 kHz, the conductivity in cancerous tissue is significantly larger than that of normal tissue (Table 2) . While not confirmed in this particular study, it is hypothesized that this relationship may arise from the larger blood volume present in the highly vascularized cancerous regions; 375 blood has a higher conductivity than normal prostatic tissues (0.6 S/m [24] vs. 0.2 S/m [10] ).
This finding is contradictory to that reported previously in multiple ex vivo studies [8] , [9] . These reports have suggested that cancerous tissue has a significantly lower conductivity than benign tissue (p < 0.05) at frequencies ranging from 0.1 kHz to 100 kHz, and that the permittivity of cancerous tissue is significantly greater than that of normal tissues at 100 kHz (p < 0.0001) [10] .
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These contradictory findings may stem from differences between in vivo and ex vivo tissue properties. The effect of blood-concentrated vascularization may be the dominating factor influencing the electrical properties within the cancer region in in vivo tissues, while under ex vivo conditions the blood leaves the prostate and tissue architecture and cell density become the primary factors affecting electrical properties. It is worth noting that conductivity relationships at 385 102.4 kHz in this in vivo study were opposite from that observed at the other lower frequencies.
Specifically, tumor conductivity is significantly smaller than benign tissue (p = 0.0315), which possibly results from a more prominent effect from cell morphology at these higher frequencies, as suggested in previous ex vivo studies [8] - [10] . Further studies recording electrical properties from both in vivo and ex vivo prostate tissue are needed to better understand these opposing 390 findings.
The significantly larger conductivity observed in cancer tissues (i.e. >0) at frequencies lower than 25.6 kHz was true for a majority of the men; σ c was larger than σ b in more that 66.67% of all cases. Despite this, when pixel values from all men are combined the significance is lost
is not significantly different from ). This is due to considerably large variation
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(standard deviation from Table 3 ) as compared to the mean conductivities (i.e. 33.5 mS/m vs.
141.2 mS/m at 0.4 kHz, Table 3 ). This large inter-patient variability stems from a number of patient dependent conditions that occur during data acquisition including: different electrode and tissue contact impedances associated with fluid content within the rectum, slight variations in pressure applied between the imaging probe and rectal wall, minor differences in quantity and 400 distribution of acoustic gel applied to the electrodes and TRUS probe, and the inherent patientto-patient prostate tissue variation, which was also observed in previous ex vivo studies [10] . The conductivity variability reported here may make it difficult to identify a single threshold for discriminating tissue types for a general population; but, because there is a significant difference found within individual patients, it may be possible to find a patient-specific threshold for each
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EIT scan. For example, binary classifying algorithms (i.e. k-means, receiver-operator characteristics) could be developed to separate pixels into two categories (tumor and benign) if there is sufficient contrast within an individual image. This contrast appears to be present (Table   2 ) which would enable these algorithms to extract a patient-specific threshold. These are highspeed algorithms that could be applied to the data in real-time to assess cancer presence and 410 uniquely identify image pixels containing cancerous tissue.
In this study, pathological slices are assumed to be of equal thickness; however, in practice the whole prostate is sliced manually with slice thicknesses ranging from 3-5 mm. This imprecision may lead to small errors in correlating EIT images with pathology maps since there may be small offsets between the actual axial location of an EIT slice in relation to the 415 pathological slice. Recording the exact thickness of each slice might mitigate this error, which should be considered in future research.
The influence that the ultrasound gel and the porous membrane sheath interfacing the TREIT probe to the patient have on the recorded impedance data have been previously evaluated [18] . Phantom imaging experiments demonstrated that the interfacing material had a minor image reconstruction in EIT due to the lack of cross-prostate currents sensed far from the probe's surface. As a result, the sensitivity deteriorates with distance from this surface [25] . One way of potentially mitigating this is to include additional intra-prostatic sensors, by coupling EIT electrodes to a standard biopsy needle [26] ; this approach is currently being explored to provide 430 more trans-prostatic current, increase the distal sensitivity, and ultimately enhance transrectal electrical impedance tomography [25] .
The prostate case illustrated in Figs. 7 and 8 was characterized primarily by a large, discrete tumor mass. Although the TREIT imaging system was characterized to be able to detect a high contrast object of at least 1 cm in diameter [15] , subtle, smaller tumors may be 435 challenging to define and isolate from background benign tissue (e.g. the smaller anterior tumor was not observed in TREIT image in Fig. 8 ). Another reason these anterior foci were not observed may be due to the limited sensitivity to deep structures > 3cm from the probes surface.
We demonstrate in [15] that the system is able to detect contrast up to ~3cm from the probe surface. By incorporating needle electrodes to the imaging system, the sensitivity in these anterior regions will likely be enhanced and an overall increased resolution may help to detect smaller tumors [26] .
Because of the challenges posed by the open domain and the systematic measurement errors, we were not able to reconstruct accurate absolute EIT images. Instead, difference imaging with a reference saline bath was employed to reduce the systematic errors of the imaging system.
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Although the conductivity of the saline bath (0.1 S/m) may be different from the prostate tissue, it provides a uniform background for the reconstruction and the contrast between cancerous and benign tissue still exists in the reconstructed images.
EIT is a relatively low resolution imaging modality compared to CT or MRI due to the underlying physics defined by a diffusely propagating current through an electrically 450 heterogeneous volume. Contrasts (i.e. between tumor and benign tissues) within the imaging domain distort the electric field generated by these diffusely propagating currents. EIT requires that a non-linear numerical model be applied to estimate the internal electrical property distribution by minimizing the error between modeled and real world electrical potentials recorded from the boundary of the imaging domain. Because these boundary measurements have 455 a limited sensitivity to electrical property variations far from the site of measurement, the resolution of deep structures is limited. The 8 8 8 coarse mesh used for TREIT is adopted as a compromise between sensitivity and noise [19] . Despite the relatively low resolution associated with this coarse pixelation, lesions larger than half the size of a voxel are expected to be identified, as described in Section Method B.
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Finally, one of the most significant challenges facing urologists currently is to discriminate between aggressive and indolent tumors in the prostate [27] . Cancer volume within the prostate is significantly correlated to the disease stage [28] . TREIT may be an effective tool for accurately identifying moderate and large sized tumors with the use of the coarse mesh.
Tumor volumes exceeding a certain size can be revealed by TREIT and this may be potentially 465 used to target suspicious regions in the prostate during biopsy procedure. Two potential approaches could be used clinically based on the findings from these TREIT images: 1) additional biopsies could be extracted from regions of suspicion which would potentially reduce the number of repeat biopsy's and decrease the lack of concordance between biopsy and prostatectomy specimen assessment [29] , and 2) a currently standard 12 core protocol could be 470 reduced to a fewer core biopsy template (i.e. 6 core protocol) followed by extracting additional samples from TREIT based regions of suspicion; this would potentially decrease morbidities (i.e.
hemorrhage and infection) associated with core extraction and provide a more representative assessment of the disease within the gland.
Conclusion
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This study presents a novel method for imaging the electrical properties of prostate and for correlating reconstructed EIT images and pathological findings. Cancerous tissue is found to be significantly more conductive than normal tissue at frequencies ranging from 0.4 kHz to 25.6 kHz, while the permittivity of both tissue types is not found to be significantly different. The findings pertaining to conductivity imaging suggest that TREIT-based prostate imaging may
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have clinical potential for detecting the prostate cancer.
